Disulfiram modulates ROS accumulation and overcomes synergistically cisplatin resistance in breast cancer cell lines
The chemotherapeutic agent cisplatin typically induces apoptosis by inhibiting the cell cycle. Cancer Stem Cells (CSCs), which are a proliferative quiescent and slowly-cycling cell population, are less sensitive and therefore frequently spared from toxic effects. Thus, it remains a priority to incre...
Main Authors: | Zhi Yang, Fang Guo, Andreas E. Albers, Jalid Sehouli, Andreas M. Kaufmann |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-05-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332218379137 |
Similar Items
-
Inhibitory effect on ovarian cancer ALDH+ stem-like cells by Disulfiram and Copper treatment through ALDH and ROS modulation
by: Fang Guo, et al.
Published: (2019-10-01) -
Blockade of ALDH in Cisplatin-Resistant Ovarian Cancer Stem Cells In Vitro Synergistically Enhances Chemotherapy-Induced Cell Death
by: Guo, F., et al.
Published: (2022) -
Disulfiram overcomes bortezomib and cytarabine resistance in Down-syndrome-associated acute myeloid leukemia cells
by: Bista, Ranjan, et al.
Published: (2017) -
Refractory periungual stage II mycosis fungoides with novel LMNA-ROS1 fusion
by: Peter A. DeRosa, MD, et al.
Published: (2020-09-01) -
Repurposing Disulfiram as an Anti-Obesity Drug: Treating and Preventing Obesity in High-Fat-Fed Rats
by: Omran Z, et al.
Published: (2020-05-01)